These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7663673)

  • 21. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
    McNamara PJ; Blouin RA
    J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes.
    Urien S; Claudepierre P; Meyer J; Brandt R; Tillement JP
    Biochem Pharmacol; 1992 Nov; 44(9):1891-3. PubMed ID: 1449542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H; Rinck G; Bitterling T; Orfanos CE
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin, adipose tissue and plasma levels of acitretin with rare occurrence of esterified acitretin during long-term treatment.
    Meyer E; de Bersaques J; Lambert WE; de Leenheer AP; Kint AH
    Acta Derm Venereol; 1993 Apr; 73(2):113-5. PubMed ID: 8103254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of etretinate metabolites in human blood.
    Vane FM; Buggé JL; Rodriguez LC
    Drug Metab Dispos; 1989; 17(3):280-5. PubMed ID: 2568909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
    Berne B; Rollman O; Vahlquist A
    Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A newly discovered xenobiotic metabolic pathway: ethyl ester formation.
    Chou RC; Wyss R; Huselton CA; Wiegand UW
    Life Sci; 1991; 49(21):PL169-72. PubMed ID: 1834900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of retinoids.
    Klein J; Fernandes D; Pastuszak A; Koren G
    Ther Drug Monit; 1992 Jun; 14(3):197-202. PubMed ID: 1412605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):646-51. PubMed ID: 2575501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat.
    Vahlquist A; Rollman O; Pihl-Lundin I
    Acta Derm Venereol; 1986; 66(5):431-4. PubMed ID: 2431582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration of etretinate in plasma and subcutaneous fat after long-term acitretin.
    Maier H; Hönigsmann H
    Lancet; 1996 Oct; 348(9034):1107. PubMed ID: 8874484
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous determination of the new anticancer agent amidox and its metabolites in rat bile and plasma by high-performance liquid chromatography.
    Vielnascher E; Romanová D; Novotný L; Szekeres T; Elfort HL; Thalhammer T; Jäger W
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(2):267-74. PubMed ID: 9323547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic studies on the ethyl-esterification of acitretin by human liver preparations in vitro.
    Schmitt-Hoffmann AH; Dittrich S; Saulnier E; Schenk P; Chou RC
    Life Sci; 1995 Nov; 57(26):PL407-12. PubMed ID: 8847958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of an aromatic retinoid and its main metabolite by high-performance liquid chromatography.
    Hänni R; Hervouet D; Busslinger A
    J Chromatogr; 1979 Apr; 162(4):615-21. PubMed ID: 528672
    [No Abstract]   [Full Text] [Related]  

  • 36. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
    Rollman O; Vahlquist A
    Br J Dermatol; 1983 Oct; 109(4):439-47. PubMed ID: 6226308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acitretin in psoriasis: an overview of adverse effects.
    Katz HI; Waalen J; Leach EE
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S7-S12. PubMed ID: 10459140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J; Paravicini U
    Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of etretinate and its main metabolite in human plasma using normal-phase high-performance liquid chromatography.
    Paravicini U; Busslinger A
    J Chromatogr; 1983 Sep; 276(2):359-66. PubMed ID: 6630385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis.
    Larsen FG
    Acta Derm Venereol Suppl (Stockh); 1994; 190():1-33. PubMed ID: 7900497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.